UAB AIM Virtual Magic Camp

August 29, 2022 updated by: Hon K. Yuen, PhD

UAB Arts in Medicine's Evaluation of a Virtual Magic Camp

The magic camp for children with disabilities at UAB has been conducted yearly since 2018. This year, because of the Covid-19, the magic camp will be conducted online. The virtual magic camp will start in the beginning of June . It will run for 4 weeks. After one cohort, there will be another cohort starts in the beginning of July . Each cohort will have about 30 children with disabilities. Two occupational therapy graduate students will teach each child via Zoom to learn magic hand trick 3 times a week, one hour each. No studies evaluate the psychological benefits of learning magic tricks via online in children with disabilities. Therefore, this study is to evaluate the psychological being of the children participants after completing a virtual magic camp.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
18

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • United States
    • Alabama
      • Birmingham, Alabama, United States, 35205
        • UAB Alys Sthepens Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

9 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Participants will be with other individuals who do not have ASD.

Description

Inclusion Criteria:

  • Have some form of ASD

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
Magic Camp Session #1
Children ages 9-18
Behavioral: Autism Research
Measuring aspects such as self esteem, social skills, and social anxieties.
Magic Camp Session #2
Children ages 9-18
Behavioral: Autism Research
Measuring aspects such as self esteem, social skills, and social anxieties.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
Self Esteem
Time Frame: 2 weeks
Rosenberg Self Esteem Scale: The Rosenberg Self-Esteem Scale (Rosenberg, 1965) consists of 10 items quantifying participants' feelings about themselves on a 4-point scale (1=strongly agree; 4=strongly disagree). After taking into consideration the five reversed scored items, responses are totaled to form the summation score, ranging from 10 to 40, with the larger scores indicating higher self-esteem.
2 weeks
Strengths & Difficulties
Time Frame: 2 weeks
SDQ is a screening tool for emotional and behavioral problems in children and adolescents aged 2 to 17 years (Stone, Otten, Engels, Vermulst, & Janssens, 2010). SDQ includes 25 items across 5 subscales. Each item is rated on a 3-point scale with 0=not true, 1=somewhat true, and 2=certainly true. Responses are totaled to form the summation score, ranging from 0-50, with higher scores indicating more emotional and behavioral problems.
2 weeks
Social Anxiety
Time Frame: 2 weeks
The SAS is designed to assess feelings of social anxiety (avoidance, fears, or worries) experienced by children and adolescents in the context of their peer relations (La Greca & Lopez, 1998; La Greca & Stone, 1993). The SAS has 18 items divided into three subscales. Each item is rated on a 5-point Likert scale according to how much each item characterizes the specific feeling indicated (1 = not at all, 5 = all the time). Items from each subscale are summed so that high scores reflect greater levels of social anxiety.
2 weeks
Social Skills
Time Frame: 2 weeks
The SSIS is designed to measure various aspects of social skills in children and adolescents who are suspected of having significant social difficulties (Gresham & Elliott, 2008). The Social Skills domain has 46 items and consists of seven subscales. Items are rated on a 4-point Likert scale by indicating how true each social skill is (0 = not true, 3 = very true), with lower scores indicating poorer social skill.
2 weeks
Social Responses
Time Frame: 2 weeks
The SRS-2 is designed to measure various dimensions of interpersonal behavior, communication, and repetitive/stereotypic behavior associated with autism occurring in natural social settings (Constantino & Gruber, 2012). The SRS-2 is comprised of 65 items which are rated on a 4-point Likert scale, ranging from 1 = not true, to 4 = almost always true. Higher scores reflect a greater degree of social impairment.
2 weeks
Parental Stress
Time Frame: 2 weeks
The SIPA is a 112-item measure assessing stress within the parent-adolescent relationship (Sheras et al., 1998). The first 90 items have response options on a 5-point Likert scale (1 = strongly disagree, 2 = disagree, 3 = not sure, 4 = agree, 5 = strongly agree) and the remaining 22 items are yes (1) /no (0) questions pertaining to stressful life events the respondent may have experienced. Higher scores indicate higher levels of stress.
2 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Hon K. Yuen, PhD

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
April 7, 2021

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
August 31, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
August 31, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 7, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 7, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 12, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
August 31, 2022

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
August 29, 2022

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 300005328

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings